| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) | 
|---|
| 12/01/1992 | US5168102 Endocrine manipulation to improve body composition of poultry | 
| 12/01/1992 | US5168045 Diagnostic systems and methods using polypeptide analogs of apolipoprotein e | 
| 12/01/1992 | CA2108580A1 Treatment of hiv-associated immune thrombocytopenic purpura | 
| 12/01/1992 | CA2069671A1 Human immunodeficiency virus-related immune preparation | 
| 12/01/1992 | CA1310922C Vaccine to control the viral infection of fish | 
| 12/01/1992 | CA1310921C Vector for the expression of fusion proteins and protein immunogens | 
| 12/01/1992 | CA1310902C Autocrine motility factors in cancer diagnosis and management | 
| 11/30/1992 | CA2069765A1 Eimeria tenella dna probes | 
| 11/30/1992 | CA2069588A1 Eimeria maxima dna probes | 
| 11/30/1992 | CA2069583A1 Eimeria acervulina dna probes | 
| 11/30/1992 | CA2069573A1 Eimeria necatrix dna probes | 
| 11/30/1992 | CA2069563A1 Eimeria mitis dna probes | 
| 11/30/1992 | CA2069535A1 Eimeria praecox dna probes | 
| 11/30/1992 | CA2069533A1 Eimeria brunetti dna probes | 
| 11/28/1992 | CA2069594A1 Recombinant avipox virus, culture of cells infected by this virus and fowl vaccines derived therefrom | 
| 11/26/1992 | WO1992021033A1 Determination of motifs of peptides on mhc molecules | 
| 11/26/1992 | WO1992021029A1 Selecting ligand agonists and antagonists | 
| 11/26/1992 | WO1992020803A1 THE ASTROVIRUS HUMAN GASTROENTERITIS AGENTS AND MOLECULAR CLONING OF CORRESPONDING cDNAs | 
| 11/26/1992 | WO1992020799A1 Amino acid sequence of anticancer human monoclonal antibody and dna base sequence coding for the same | 
| 11/26/1992 | WO1992020794A1 Purification and cloning of p62 | 
| 11/26/1992 | WO1992020793A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-β SUPERFAMILY | 
| 11/26/1992 | WO1992020791A1 Methods for producing members of specific binding pairs | 
| 11/26/1992 | WO1992020787A1 Stealth virus detection in the chronic fatigue syndrome | 
| 11/26/1992 | WO1992020786A1 Hepatitis a virus production | 
| 11/26/1992 | WO1992020375A1 Non-stinging measles-mumps-rubella vaccine composition | 
| 11/26/1992 | WO1992020374A1 Ctaa 81av78, the antigen recognized by human monoclonal antibody 81av78 | 
| 11/26/1992 | WO1992020365A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression | 
| 11/26/1992 | WO1992020360A1 Method of using substance p to treat allergy | 
| 11/26/1992 | WO1992020356A1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof | 
| 11/26/1992 | WO1992020316A2 Targeted delivery of genes encoding immunogenic proteins | 
| 11/26/1992 | DE4216355A1 Verfahren zur bereitstellung von antigen-spezifischen b- und t-lymphozyten sowie davon erhaltene monoklonale antikoerper A method of providing antigen-specific B- and T-lymphocytes obtained therefrom as well as monoclonal antibodies | 
| 11/26/1992 | CA2471093A1 Determination of motifs of peptides on mhc molecules | 
| 11/26/1992 | CA2109843A1 Method of using substance p to treat allergy | 
| 11/26/1992 | CA2109603A1 Stealth virus detection in the chronic fatigue syndrome | 
| 11/26/1992 | CA2109598A1 Therapeutic and diagnostic methods based on neurotrophin-4- expression | 
| 11/26/1992 | CA2103376A1 Purification and cloning of p62 | 
| 11/26/1992 | CA2103064A1 Targeted delivery of genes encoding immunogenic proteins | 
| 11/26/1992 | CA2102422A1 Ctaa 81av78, the antigen recognized by human monoclonal antibody 81av78 | 
| 11/26/1992 | CA2086327A1 Cloning and recombinant production of receptor(s) of the activin/tgf- .beta. superfamily | 
| 11/25/1992 | EP0514721A1 Peptides having thrombospondin-like activity and their therapeutic use | 
| 11/25/1992 | EP0514481A1 Merosin, nucleic acids encoding, fragments and uses thereof | 
| 11/25/1992 | EP0514458A1 Assays and treatments for autoimmune diseases | 
| 11/25/1992 | EP0514413A1 Immunologically active peptides or polypeptides from the parvovirus b19. | 
| 11/25/1992 | EP0514411A1 Polypeptides and dna encoding same, associated with human malaria parasites | 
| 11/25/1992 | EP0348399B1 Sorbin and peptide derivatives which increase aborption by the mucous membranes | 
| 11/25/1992 | EP0248084B1 Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl) derivatives | 
| 11/25/1992 | EP0139676B1 Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins | 
| 11/24/1992 | US5166319 Interfacial condensation of bioactive compounds and the site-specific compounds and conjugates thereof | 
| 11/24/1992 | US5166057 Templates for gene expression | 
| 11/24/1992 | US5165927 Cysteine modified to reduce ADP-ribosyl transferase activity | 
| 11/24/1992 | US5165925 Vaccine for immunizing fish against infectious pancreatic necrosis virus | 
| 11/24/1992 | US5165924 Serum-free, cell-free vaccine effective against pneumonic pasteurellosis in cattle | 
| 11/24/1992 | US5165922 Treatment of breast cancer | 
| 11/24/1992 | US5165912 Reagents for diagnosis with antibodies reactive with enzymes | 
| 11/23/1992 | CA2063055A1 Peptides having thrombospondin-like activity and their therapeutic use | 
| 11/21/1992 | CA2102292A1 The astrovirus human gastroenteritis agents and molecular cloning of corresponding cdnas | 
| 11/19/1992 | EP0514208A1 Non-stinging measles-mump-rubella vaccine composition | 
| 11/19/1992 | EP0514199A2 Vaccines and methods for their production | 
| 11/19/1992 | EP0513921A2 Recombinant vaccine against Marek's disease | 
| 11/19/1992 | EP0513861A1 Vaccine adjuvant comprising a tetra-polyol | 
| 11/19/1992 | EP0513778A2 Hybrid monoclonal antibodies and compositions containing them | 
| 11/19/1992 | EP0513565A1 Monoclonal antibodies against the plasmin-antiplasmin complex, process for their preparation and their use | 
| 11/19/1992 | EP0513371A1 Human parainfluenza virus type 4a fusion protein and gene which codes for the same | 
| 11/19/1992 | EP0513242A1 Lipopolysaccharide binding opsonin and methods of use thereof | 
| 11/19/1992 | EP0513225A1 Enzyme treated bcg vaccine and process therefor | 
| 11/19/1992 | EP0513090A1 Hepatitis a vaccines | 
| 11/19/1992 | DE4115910A1 Prodn. of native and stable immunoglobulin - by extraction form total globulin with aq. methanol at specified pH, to provide IgG as prophylactic agent | 
| 11/18/1992 | WO1992020364A1 Cytokine receptor targeted molecules for treatment of meoplastic cell growth | 
| 11/18/1992 | CN1019133B Monoclonal antibodies to pseudomonas aeruginosa flagella | 
| 11/18/1992 | CN1019132B Anti-urokinase monoclonal antibody, matrix bearing it, test method and biochemical test kits which use it | 
| 11/18/1992 | CA2103258A1 Cytokine receptor targeted molecules for treatment of neoplastic cell growth | 
| 11/18/1992 | CA2068817A1 Vaccines and methods for their production | 
| 11/18/1992 | CA2068813A1 Hybrid monoclonal antibodies and compositions containing them | 
| 11/18/1992 | CA2068742A1 Non-stinging vaccine composition | 
| 11/17/1992 | WO1992020783A1 Process for preparing antigen-specific b and t lymphocytes and monoclonal antibodies obtained therefrom | 
| 11/17/1992 | US5164489 Protein growth factor useful in diagnosis and treatment of lung cancer | 
| 11/17/1992 | US5164487 Manufacturing intravenous tolerable immunoglobulin-g preparation | 
| 11/17/1992 | US5164485 Modified hepatitis B virus surface antigen P31 and production thereof | 
| 11/17/1992 | US5164481 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus | 
| 11/17/1992 | US5164296 Cardiovascular, renal | 
| 11/17/1992 | CA2087157A1 Process for preparing antigen-specific b and t lymphocytes and monoclonal antibodies obtained therefrom | 
| 11/17/1992 | CA2068764A1 Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof | 
| 11/17/1992 | CA1310265C Process for the preparation of an organ-specific substance labeled with technetium-99m | 
| 11/17/1992 | CA1310264C Modified antibodies for enhanced clearance | 
| 11/15/1992 | WO1992020373A1 Heteroconjugate antibodies for treatment of hiv infection | 
| 11/15/1992 | CA2102511A1 Heteroconjugate antibodies for treatment of hiv infection | 
| 11/14/1992 | WO1992020805A1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence | 
| 11/14/1992 | WO1992020370A1 Liposomal polysaccharide vaccines | 
| 11/14/1992 | CA2109316A1 Liposomal polysaccharide vaccines | 
| 11/12/1992 | WO1992019973A1 Novel antibodies, and methods for their use | 
| 11/12/1992 | WO1992019969A1 Immunoassay for detecting group b streptococcus | 
| 11/12/1992 | WO1992019759A1 Reconstituted human antibody against human interleukin 6 receptor | 
| 11/12/1992 | WO1992019758A1 Transmission-blocking vaccine against malaria | 
| 11/12/1992 | WO1992019750A1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor | 
| 11/12/1992 | WO1992019748A1 Herpesvirus particles and vaccine | 
| 11/12/1992 | WO1992019746A1 Recombinant immunocastration vaccine and polypeptides useful for same | 
| 11/12/1992 | WO1992019743A2 Hcv genomic sequences for diagnostics and therapeutics | 
| 11/12/1992 | WO1992019741A1 Hbv virus surface proteins with reduced host carbohydrate | 
| 11/12/1992 | WO1992019740A1 Multiple hepatitis b virus surface proteins which form particles | 
| 11/12/1992 | WO1992019735A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND |